Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line
In this study, we present the synthesis, kinetic studies of inhibitory activity toward aldo-keto reductase 1C (AKR1C) enzymes, and anticancer potential toward chemoresistant ovarian cancer of 10 organoruthenium compounds bearing diketonate (1-6) and hydroxyquinolinate (7-10) chelating ligands with t...
Saved in:
Main Authors: | Jakob Kljun (Author), Renata Pavlič (Author), Eva Hafner (Author), Tanja Lipec (Author), Sara Moreno-Da Silva (Author), Primož Tič (Author), Iztok Turel (Author), Tomaž Büdefeld (Author), Jure Stojan (Author), Tea Lanišnik Rižner (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enzymes of the AKR1B and AKR1C subfamilies and uterine diseases
by: Tea eLanisnik Rizner
Published: (2012) -
Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives
by: Maša Sinreih, et al.
Published: (2021) -
Expression of the Aldo-Keto Reductases AKR1B1 and AKR1B10 in Human Cancers.
by: Brian eLaffin, et al.
Published: (2012) -
AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategies
by: Mengnan Li, et al.
Published: (2024) -
Basal and regulatory promoter studies of the aldo-keto reductase 1C3 (AKR1C3) gene in relation to prostate cancer
by: Jenny J Schulze, et al.
Published: (2012)